Active Motif

Active Motif

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

Active Motif is a leading provider of research tools in the rapidly growing field of epigenetics, operating as a private, revenue-generating company. It has established a strong reputation over two decades for high-quality antibodies, innovative assay kits, and custom service capabilities like ChIP-seq. While not a therapeutic developer, its platform enables critical discovery research across academia and industry, positioning it as an essential enabler in the genomics and drug discovery value chain. The company's success is tied to the continued expansion of epigenetics research and the demand for reliable, standardized research reagents.

Antibodies

Technology Platform

Integrated platform for epigenetics research, including high-specificity antibodies, assay kits (e.g., ChIP-seq), and custom services for chromatin analysis and next-generation sequencing.

Funding History

2
Total raised:$20M
Series B$12M
Series A$8M

Opportunities

Growth is driven by the expanding field of epigenetics research, increased outsourcing of complex genomic services by academic and biopharma labs, and the need for validated tools in biomarker discovery and drug development.
Expansion of bioinformatics and data analysis services presents a high-margin growth avenue.

Risk Factors

Faces intense competition from larger, diversified life science suppliers.
Reliant on consistent research funding, particularly from government sources.
Technological shifts in research methods could disrupt demand for existing products.

Competitive Landscape

Competes with large reagent conglomerates like Thermo Fisher Scientific and Merck Millipore, as well as focused antibody companies like Cell Signaling Technology and Abcam. Differentiates through deep specialization in epigenetics, rigorous antibody validation, and a strong integrated service model for ChIP-seq.